Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130297 · ClinicalTrials.gov registry record · NA
Post Excision/Mohs Scar Laser Resurfacing
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02130297 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 30 participants.
The verdict
NCT02130297, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the potential benefits of treating a surgical scar post excision with an ablative fractionated CO2 laser with the goal of decreasing the appearance and size of the scar.
Interventions
- DEVICE Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02130297
The ClinicalTrials.gov registry entry for NCT02130297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laser Treatment is the first listed.
NCT02130297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02130297 about?
NCT02130297 is a clinical study titled "Post Excision/Mohs Scar Laser Resurfacing". The purpose of this study is to evaluate the potential benefits of treating a surgical scar post excision with an ablative fractionated CO2 laser with the goal of decreasing the appearance and size of the scar.
What is the current status of trial NCT02130297?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-05. Estimated completion is 2019-03-19.
What interventions are being tested in trial NCT02130297?
The interventions under investigation include: Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT02130297?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.